Your browser is no longer supported. Please, upgrade your browser.
Settings
SCLN SciClone Pharmaceuticals, Inc. daily Stock Chart
SCLN [NASD]
SciClone Pharmaceuticals, Inc.
Index- P/E16.07 EPS (ttm)0.57 Insider Own0.60% Shs Outstand49.60M Perf Week-3.27%
Market Cap454.34M Forward P/E- EPS next Y- Insider Trans-41.72% Shs Float44.66M Perf Month-1.08%
Income30.00M PEG1.14 EPS next Q0.11 Inst Own76.00% Short Float9.08% Perf Quarter2.35%
Sales141.80M P/S3.20 EPS this Y140.00% Inst Trans3.12% Short Ratio9.83 Perf Half Y4.57%
Book/sh3.27 P/B2.80 EPS next Y- ROA16.50% Target Price9.00 Perf Year74.48%
Cash/sh1.94 P/C4.73 EPS next 5Y14.10% ROE19.00% 52W Range4.68 - 9.87 Perf YTD4.57%
Dividend- P/FCF13.52 EPS past 5Y13.90% ROI16.00% 52W High-7.19% Beta2.09
Dividend %- Quick Ratio7.00 Sales past 5Y13.20% Gross Margin83.80% 52W Low95.73% ATR0.27
Employees570 Current Ratio7.50 Sales Q/Q26.30% Oper. Margin21.70% RSI (14)48.90 Volatility2.68% 2.75%
OptionableYes Debt/Eq0.00 EPS Q/Q112.50% Profit Margin21.20% Rel Volume1.04 Prev Close9.36
ShortableYes LT Debt/Eq0.00 EarningsAug 10 AMC Payout0.00% Avg Volume412.69K Price9.16
Recom2.50 SMA20-1.64% SMA500.49% SMA20010.54% Volume421,500 Change-2.14%
Nov-14-14Downgrade BWS Financial Buy → Hold $8.25 → $8
Nov-12-13Reiterated Aegis Capital Buy $9 → $8
Jul-16-13Upgrade Aegis Capital Hold → Buy $9
Sep-18-12Upgrade BWS Financial Hold → Buy $8.25
Aug-10-10Downgrade BWS Financial Buy → Hold $7.25 → $4.50
Apr-09-10Upgrade BWS Financial Hold → Buy $7.25
Jul-08-09Downgrade BWS Financial Buy → Hold $3.25
Jun-03-09Initiated ThinkEquity Buy $5
May-21-09Initiated Rodman & Renshaw Mkt Outperform $5
Sep-05-08Initiated Susquehanna Financial Neutral
Jun-27-15 03:02AM  Edited Transcript of SCLN presentation 3-Jun-15 2:30pm GMT
Jun-20-15 03:45AM  Edited Transcript of SCLN earnings conference call or presentation 11-May-15 8:30pm GMT
Jun-17-15 04:40PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to
Jun-16-15 09:08AM  Buy These 6 Risky Pharmaceutical Stocks for Big Upside Potential at TheStreet
May-27-15 11:54AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:05AM  Theravance Biopharma and SciClone Pharmaceuticals Enter Into Development and Commercialization Agreement for VIBATIV(R) (Telavancin) in China Marketwired
08:05AM  SciClone Pharmaceuticals and Theravance Biopharma Enter Into Development and Commercialization Agreement for VIBATIV(R) (Telavancin) in China Marketwired
May-26-15 06:00AM  SciClone to Present at Jefferies 2015 Global Healthcare Conference on June 3, 2015 Marketwired
May-21-15 09:00AM  Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00 Marketwired -5.39%
May-19-15 01:04PM  SCICLONE PHARMACEUTICALS INC Financials
May-13-15 08:11PM  10-Q for SciClone Pharmaceuticals, Inc. at Company Spotlight
May-11-15 05:24PM  SciClone posts 1Q profit
04:30PM  SciClone Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
04:07PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
07:07AM  Q1 2015 SciClone Pharmaceuticals Inc Earnings Release - After Market Close
May-05-15 08:12PM  10-K for SciClone Pharmaceuticals, Inc. at Company Spotlight
Apr-30-15 06:32AM  SciClone Pharmaceuticals to Report Financial Results for the First Quarter 2015 on May 11th at noodls
06:00AM  SciClone Pharmaceuticals to Report Financial Results for the First Quarter 2015 on May 11th Marketwired
Apr-06-15 04:09PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
06:03AM  SciClone to Present at Needham Healthcare Conference on April 14, 2015 at noodls
06:00AM  SciClone to Present at Needham Healthcare Conference on April 14, 2015 Marketwired
Mar-19-15 06:04AM  SciClone to Present at Investor and Partnering Conferences in China at noodls
06:00AM  SciClone to Present at Investor and Partnering Conferences in China Marketwired
Mar-12-15 05:27PM  SCICLONE PHARMACEUTICALS INC Files SEC form 10-K, Annual Report +9.80%
09:20AM  SciClone (SCLN) Beats on Q4 Earnings, Gives 2015 Outlook - Analyst Blog
Mar-11-15 05:07PM  SciClone posts 4Q profit
04:50PM  SciClone Reports 2014 Financial Results and 2015 Outlook at noodls
04:30PM  SciClone Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
04:08PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:05PM  SciClone Reports 2014 Financial Results and 2015 Outlook Marketwired
07:07AM  Q4 2014 SciClone Pharmaceuticals Inc Earnings Release - After Market Close
Feb-25-15 06:15AM  SciClone Pharmaceuticals to Report Financial Results for the Fourth Quarter and Full Year 2014 on March 11th at noodls
06:00AM  SciClone Pharmaceuticals to Report Financial Results for the Fourth Quarter and Full Year 2014 on March 11th Marketwired
Jan-28-15 04:05PM  Correction: SciClone to Present at BIO CEO & Investor Conference on February 9, 2015 at 11 am ET Marketwired
06:00AM  SciClone to Present at BIO CEO & Investor Conference on February 9, 2015 Marketwired
Jan-06-15 12:22PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
06:00AM  SciClone Provides 2014 Financial Update and 2015 Revenue Guidance Marketwired
Dec-18-14 12:56PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +5.10%
Nov-14-14 12:19PM  SciClone Pharma downgraded by BWS Financial Briefing.com
Nov-12-14 07:09PM  10-Q for SciClone Pharmaceuticals, Inc. Company Spotlight +5.22%
Nov-10-14 04:30PM  SciClone Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today CCBN +5.06%
04:08PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
04:05PM  SciClone Reports Financial Results for the Third Quarter 2014 Marketwired
07:07AM  Q3 2014 SciClone Pharmaceuticals Inc Earnings Release - After Market Close CCBN
Nov-06-14 06:00AM  SciClone to Present at Jefferies Global Healthcare Conference on November 19th Marketwired
Nov-03-14 12:34PM  Story Stocks from Briefing.com Briefing.com
Oct-30-14 06:00AM  SciClone Pharmaceuticals to Report Financial Results for the Third Quarter 2014 on November 10th Marketwired
Sep-17-14 06:00AM  SciClone to Present at BioCentury NewsMakers in the Biotech Industry Conference on September 26, 2014 Marketwired
Sep-03-14 06:00AM  SciClone to Present at Aegis 2014 Healthcare & Technology Conference on September 11, 2014 Marketwired
Aug-28-14 11:17AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
02:00AM  SciClone and BTG Announce That DC Bead(R) Has Been Approved by China Food and Drug Administration Marketwired
Aug-11-14 04:30PM  SciClone Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:09PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
04:05PM  SciClone Reports Financial Results for the Second Quarter 2014 Marketwired
07:07AM  Q2 2014 SciClone Pharmaceuticals Inc Earnings Release - After Market Close CCBN
Jul-31-14 06:00AM  SciClone Pharmaceuticals to Report Financial Results for the Second Quarter 2014 on August 11th Marketwired
Jun-13-14 12:05PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Jun-11-14 09:00AM  Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); $5.50 Price Target Marketwired
May-27-14 06:00AM  SciClone to Present at Jefferies 2014 Global Healthcare Conference on June 3, 2014 Marketwired
May-12-14 11:59AM  SciClone Pharmaceuticals' (SCLN) CEO Friedhelm Blobel on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha +6.28%
08:30AM  SciClone Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
08:25AM  SciClone Pharmaceuticals (SCLN) Q4 2013 Results - Earnings Call Webcast at Seeking Alpha
07:07AM  Q1 2014 SciClone Pharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
06:09AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
06:02AM  SciClone reports Q1 adjusted EPS 10c, one estimate 8c at theflyonthewall.com
06:00AM  SciClone Reports Financial Results for the First Quarter 2014 Marketwired
May-05-14 06:00AM  SciClone Pharmaceuticals to Report Financial Results for the First Quarter 2014 on May 12th Marketwired
Apr-23-14 06:00AM  SciClone Pharmaceuticals Selects rfXcel to Meet China Product Compliance and Anti-Counterfeiting Goal Business Wire
Apr-01-14 06:00AM  SciClone to Present at Needham Healthcare Conference on April 8, 2014 Marketwired
Mar-18-14 09:00AM  Vista Partners Initiates Coverage on Soligenix, Inc. (Ticker: SNGX); $5.50 Price Target Marketwired
Mar-17-14 04:52PM  SciClone Reserves $2 Million For FCPA Settlement at The Wall Street Journal
03:33PM  SCICLONE PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online
Mar-12-14 01:15PM  SciClone Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
08:30AM   Q4 2013 SciClone Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
07:07AM  Q4 2013 SciClone Pharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
06:12AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
06:00AM  SciClone Reports 2013 Financial Results and 2014 Outlook Marketwired
Mar-03-14 06:00AM  SciClone Pharmaceuticals to Report Financial Results for the Fourth Quarter and Full Year 2013 on March 12th Marketwired
Feb-14-14 02:23PM  People Moves: Milbank, MoneyGram, SciClone, SEC at The Wall Street Journal
Feb-10-14 06:00AM  SciClone Appoints Charles Meng as General Counsel and Vice President of Compliance Marketwired
Feb-03-14 06:00AM  SciClone to Present at BIO CEO & Investor Conference on February 11, 2014 Marketwired
Jan-30-14 06:06PM  Nasdaq stocks posting largest percentage increases AP
Jan-27-14 10:15PM  Harwood Feffer LLP Announces Investigation of SciClone Pharmaceuticals, Inc. PR Newswire -12.65%
04:30PM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of SciClone Pharmaceuticals, Inc. PR Newswire
10:08AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors SciClone Pharmaceuticals, Inc. PR Newswire
Jan-24-14 06:30PM  SciClone Announces Transition From Pricewaterhousecoopers LLP to Pricewaterhousecoopers Zhong Tian LLP as Independent Registered Public Accounting Firm Marketwired
05:57PM  SciClone says material weakness found in controls at theflyonthewall.com
05:02PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements EDGAR Online
Jan-16-14 02:15PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fin EDGAR Online
Jan-15-14 07:00AM  4 Stocks Under $10 Moving Higher at TheStreet
Jan-09-14 11:59AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
06:00AM  SciClone Provides 2013 Financial Update and 2014 Guidance Marketwired
Jan-02-14 03:45PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and EDGAR Online
Dec-02-13 06:00AM  SciClone to Present at Oppenheimer Healthcare Conference on December 10, 2013 Marketwired
Nov-14-13 04:16PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statement EDGAR Online
Nov-12-13 05:13PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online +7.16%
01:20PM  SciClone Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
08:30AM  SciClone Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
08:25AM  SciClone Pharmaceuticals, Inc. Discusses Q2 2013 Results (Webcast) at Seeking Alpha
07:07AM  Q3 2013 SciClone Pharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
SciClone Pharmaceuticals, Inc., a specialty pharmaceutical company, provides therapies for oncology, infectious diseases, and cardiovascular disorders in the People's Republic of China, the United States, and Hong Kong. Its lead product is ZADAXIN, which is used for the treatment of hepatitis B and hepatitis C viruses, and certain cancers, as well as for use as a vaccine adjuvant, and as a chemotherapy adjuvant for cancer patients with weakened immune systems. The company also focuses on development ZADAXIN for the treatment of sepsis. ZADAXIN has approval in approximately 30 countries, which include China, the Pacific Rim, Latin America, Eastern Europe, and the Middle East regions. The company markets and sells ZADAXIN through distribution arrangements, local importers, and distributors. In addition, it markets approximately seven partnered products in China, including Aggrastat, an interventional cardiology product. Further, the company holds license, promotion, distribution, or marketing agreements with various parties for products, including DC Bead, Holoxan, Mesna, Endoxan, Methotrexate, Estracyt, Farlutal, Neucardin, ProFlow, Angiomax, and Cleviprex. SciClone Pharmaceuticals, Inc. also has an agreement with MEDA Pharma GmbH & Co. KG for the development of Tramadol. The company was founded in 1989 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blobel FriedhelmPresident & CEOJun 26Option Exercise2.4910,00024,900212,273Jun 29 01:49 PM
Blobel FriedhelmPresident & CEOJun 26Sale9.2910,00092,910202,273Jun 29 01:49 PM
Blobel FriedhelmPresident & CEOJun 19Option Exercise2.4910,00024,900212,273Jun 22 01:02 PM
Blobel FriedhelmPresident & CEOJun 19Sale9.4210,00094,153202,273Jun 22 01:02 PM
Blobel FriedhelmPresident & CEOJun 12Option Exercise2.4910,00024,900212,273Jun 15 04:10 PM
Meng ChuncaiGen. Counsel & VP ComplianceJun 12Option Exercise4.523,00713,5923,007Jun 15 04:13 PM
Meng ChuncaiGen. Counsel & VP ComplianceJun 12Sale9.233,00727,7550Jun 15 04:13 PM
Blobel FriedhelmPresident & CEOJun 12Sale9.1310,00091,304202,273Jun 15 04:10 PM
Zhao HongCEO, China OperationsJun 08Option Exercise4.5210,00045,20010,000Jun 09 11:15 AM
Zhao HongCEO, China OperationsJun 08Sale9.2310,00092,3380Jun 09 11:15 AM
Blobel FriedhelmPresident & CEOJun 05Option Exercise2.4910,00024,900212,273Jun 08 01:34 PM
Blobel FriedhelmPresident & CEOJun 05Sale9.0710,00090,705202,273Jun 08 01:34 PM
Hawkins Richard JDirectorJun 01Option Exercise3.274,57014,9444,570Jun 02 06:10 PM
Hawkins Richard JDirectorJun 01Sale9.274,57042,3710Jun 02 06:10 PM
Hawkins Richard JDirectorMay 29Option Exercise3.2710,43034,10610,430Jun 01 01:33 PM
Blobel FriedhelmPresident & CEOMay 29Option Exercise2.4910,00024,900211,273Jun 01 01:32 PM
Hawkins Richard JDirectorMay 29Sale9.3210,43097,1820Jun 01 01:33 PM
Blobel FriedhelmPresident & CEOMay 29Sale9.3810,00093,821201,273Jun 01 01:32 PM
Hawkins Richard JDirectorMay 26Sale9.4411,982113,1450May 26 05:38 PM
Blobel FriedhelmPresident & CEOMay 22Option Exercise2.4910,00024,900211,273May 26 02:21 PM
Blobel FriedhelmPresident & CEOMay 22Sale9.4010,00094,014201,273May 26 02:21 PM
Hawkins Richard JDirectorMay 21Sale9.713,70035,91411,982May 26 11:45 AM
Meng ChuncaiGen. Counsel & VP ComplianceMay 18Option Exercise4.5223,660106,94323,660May 19 01:33 PM
Meng ChuncaiGen. Counsel & VP ComplianceMay 18Sale9.5623,660226,0710May 19 01:33 PM
Xie LanVP Finance, China CFOMay 15Option Exercise4.8326,668128,73312,188May 18 07:54 PM
Blobel FriedhelmPresident & CEOMay 15Option Exercise2.4910,00024,900222,973May 18 07:34 PM
Xie LanVP Finance, China CFOMay 15Sale9.2026,668245,3460May 18 07:54 PM
Blobel FriedhelmPresident & CEOMay 14Option Exercise0.0080,5170212,973May 18 07:34 PM
Zhao HongCEO, China OperationsMay 14Option Exercise0.0012,500012,500May 18 08:00 PM
Zhao HongCEO, China OperationsMay 14Sale9.0712,500113,3750May 18 08:00 PM
Hawkins Richard JDirectorMay 14Sale9.1618,727171,57115,682May 18 07:41 PM
Blobel FriedhelmPresident & CEOApr 24Option Exercise2.4910,00024,900177,652Apr 24 07:02 PM
Blobel FriedhelmPresident & CEOApr 24Sale9.0710,00090,667167,652Apr 24 07:02 PM
Blobel FriedhelmPresident & CEOApr 10Option Exercise2.4910,00024,900177,652Apr 13 03:57 PM
Blobel FriedhelmPresident & CEOApr 10Sale9.1010,00091,006167,652Apr 13 03:57 PM
Cheung Wilson Wai-ShunCFO & Senior VP, FinanceMar 12Sale9.077,80370,7730Mar 16 11:26 AM
SAXE JON SDirectorMar 04Option Exercise3.2730,00098,10075,000Mar 05 02:34 PM
CHANG NANCY TDirectorFeb 12Option Exercise5.1729,019149,99754,059Feb 13 04:28 PM
Hawkins Richard JDirectorDec 11Sale8.827406,52734,409Dec 11 07:01 PM
Hawkins Richard JDirectorDec 10Sale8.7914,851130,61035,149Dec 11 07:01 PM
Hawkins Richard JDirectorSep 29Option Exercise4.5550,000227,50050,000Oct 01 04:43 PM
CHANG NANCY TDirectorAug 15Buy6.0025,040150,22225,040Aug 19 06:54 PM
Cheung Wilson Wai-ShunCFO & Senior VP, FinanceAug 14Option Exercise0.0012,500012,500Aug 18 02:53 PM